0001140361-23-034793.txt : 20230717 0001140361-23-034793.hdr.sgml : 20230717 20230717160536 ACCESSION NUMBER: 0001140361-23-034793 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230714 FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZERBE ROBERT L MD CENTRAL INDEX KEY: 0001220363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 231091689 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 form4.xml X0508 4 2023-07-14 0000887359 Vericel Corp VCEL 0001220363 ZERBE ROBERT L MD C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true true Common Stock 2023-07-14 4 S 0 1000 38.84 D 33395 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2022. /s/ Sean Flynn, as Attorney-in-Fact for Robert Zerbe 2023-07-17